NCT05170607Active, not recruiting
Investigation of Specific Biomarkers in Patients With Atrial Fibrillation Who Undergo Interventional Treatment
Source: ClinicalTrials.gov · Last updated 26 Aug 2026
Brief summary (registry, in English)
The two main mechanisms for atrial fibrillation (AF) recurrence after cryoablation include Pulmonary vein (PV) reconnection and the presence of non-PV associated arrhythmic focuses. The aim of this study is to reveal the specific biomarkers by antibody microarrays.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 24 Dec 2021
- Start date
- 1 Jan 2021
- Primary completion date
- 31 Jan 2028
- Lead sponsor
- National Medical Research Center for Therapy and Preventive Medicine
- Diseases
- Atrial fibrillation
- NCT number
- NCT05170607
What you commit to
- Study type: Observational
- Planned participants: 120
- From 1 Jan 2021 to the primary completion date, 31 Jan 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- artificial valve replacement surgery
Other illness
- chronic kidney disease requiring dialysis
- chronic kidney disease requiring dialysis
- decompensated heart failure
- stroke within the last 3 months
- myocardial infarction within the last 3 months
- coronary artery disease requiring revascularization
- heart transplant
Other
- permanent AF
- contraindications to oral anticoagulation or heparin
- untreated hypo- or hyperthyroidism
- breast feeding
- pregnancy
- Percutaneous coronary intervention or Coronary Artery Bypass Grafting within the last 3 months
- active myocarditis
- severe mitral or aortic stenosis
Who the study is looking for
- Patient with paroxysmal/persistent atrial fibrillation who underwent interventional treatment
Age in the registry: 18 years to 85 years · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Research Center for Preventive Medicine Coordinator of this site? Confirm its status | Moscow | Russia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.